ABSTRACT: Staphylococcus aureus (S. aureus) is the most popular pathogen found in septic arthritis. Despite bacteria was eradicated from joint cavity during acute infection, destruction of articular cartilage often continues for years, leading to permanent joint damage. The mechanism responsible for this consistent catabolic reaction in septic arthritis remains unclear. Here, we found that fermentation supernatant (FS) of S. aureus accelerated dedifferentiation of chondrocytes and induced expression of catabolic factors including A Disintegrin-like and Metalloproteinase with Thrombospondin-1 motifs 5, NO synthase 2, matrix metalloproteinase-3, -13. In response to FS of S. aureus stimulation, expression of antimicrobial peptides (AMPs) including b-defensin-1, -2, -3, -4, cathelicidin antimicrobial peptide (CAMP) in dedifferentiated chondrocytes was significantly higher than that in chondrocytes which maintained their differentiated phenotype. Among AMPs detected, expression of CAMP in dedifferentiated chondrocytes was observed to increase 170 times higher than that in differentiated ones. When exposed to FS of S. aureus, expression of interleukin (IL)-1b, IL-17F, and IL-22 were remarkably increased in dedifferentiated chondrocytes. These results indicated that dedifferentiation of chondrocytes caused by exposure to S. aureus might be responsible for secondary osteoarthritis (OA) after acute S. aureus infection in joint. While, one potential benefit of dedifferentiation resulted from S. aureus exposure is that chondrocytes initiates a self-protective responsiveness by producing more AMPs against bacterial infection. ß
Septic arthritis is a rapidly progressing disease, which is associated with synovial inflammation, cartilage, and bone destruction and eventually joint deformity.
1,2
Staphylococcus aureus (S. aureus) is the most common pathogens found in bacterial arthritis in adult and was reported be responsible for 37-56% of all cases of septic arthritis. 3 Cartilage destruction in septic arthritis is usually attributed to the direct toxic effect of S. aureus on chondrocytes. 4 In addition, several studies have shown that release of cytokines and proteases as a result of S. aureus infection leads to acute degradation of cartilage extracellular matrix (ECM) within even a few days. [5] [6] [7] However, one major frustration in treating bacterial arthritis in clinic is that, despite eradication of bacteria from the joint cavity, destruction of the joint cartilage triggered by an acute S. aureus infection often continues, resulting in permanent joint damage with persistent expression of catabolic factors including matrix metalloproteinases (MMPs) and inducible NO synthase (iNOS). 1, 2 Up to now, little is known about the mechanism responsible for consistent expression of catabolic factors in septic arthritis that initiated by even a transient bacterial infection.
In response to a complex profile of signals from local and systemic pathological circumstances, chondrocytes acquired a dedifferentiated phenotype with enhanced expression of collagen type I (COL I) and type III (COL III), and loss of collagen type II (COL II) production. [8] [9] [10] In addition, exposed to inflammatory cytokines such as interleukin (IL)-1b and TNF-a results in production of MMPs by chondrocytes, leading to cartilage destruction, and eventually fibrocartilage formation. 11, 12 It has been reported that introduction of group A streptococcus (GAS) induced septic arthritis with high levels of IL1-b and TNF-a in infected joints. 13 Furthermore, Sakurai et al. revealed that GAS infection increased MMP-13 expression in chondrocytes. However, whether infection of S. aureus would induce dedifferentiation of chondrocytes remains unclear.
Antimicrobial peptides (AMPs) are evolutionarily conserved elements of the innate immune system, which show activity against a wide range of viral, bacterial, and fungal pathogens.
14 Expression of lysozyme, lactoferrin, CAP-37, and human b-defensin-1 (HBD-1) have been identified in healthy articular cartilage under non-inflammatory circumstances. More importantly, strongly increased expression of mouse b-defensin (MBD)-2, -3, and -4 was detected in articular cartilage after inoculation by S. aureus in septic arthritis mouse model. 15 These results indicate that chondrocytes possess self-protective ability against infection S. aureus. However, whether dedifferentiated chondrocytes present in osteoarthritic cartilage that exposed to S. aureus maintained their ability to produce AMPs remains unclear.
In this study, we investigated effect of fermentation supernatant (FS) of S. aureus on dedifferentiation of mouse articular chondrocytes. Expression of AMPs was examined in either differentiated (passage 2) or dedifferentiated (passage 4) chondrocytes that exposed to FS of S. aureus.
MATERIALS AND METHODS
Harvest, Culture, and Expansion of Mice Articular Chondrocytes All animal procedures were approved by the Animal Care and Experiment Committee of Shanghai Tongji University School of Medicine. Mouse articular chondrocytes were released from articular cartilage of C57BL/6J mice of 7 days old by enzymatic digestion. Briefly, the cartilage were digested with 0.2% NB4 collagenase (Serva, Germany) for 6 h at 37˚C. After neutralization with low glucose Dulbecco's modified Eagle's medium (DMEM) (Gibco, Carlsbad, CA) containing 10% fetal bovine serum (FBS) (HyClone, Logan, UT), cells were centrifuged, and resuspended in DMEM supplemented with 10% FBS and 1% penicillin-streptomycin (HyClone). The cells were maintained at 37˚C in 5% humidified CO 2 with the medium changed every 2 days. When reached confluence, cells were subcultured to indicated passages.
Dedifferentiation of cultured chondrocytes was determined by examining expression of Sox9 and type I, II, III collagen by quantitative real-time PCR (qPCR), and Western blot analysis, respectively.
Treatment of Chondrocytes With FS of S. Aureus S. aureus purchased from ATCC (ATCC25923) were grown in tryptic soy broth (TSB) (AOBOX, China). Fermented was carried out at 37˚C by shaking culture for 20 h with a 3% inoculum. FS was obtained by centrifugation at 1500 g/min for 10 min and followed by filtration with 0.22-mm cellulose nitrate membrane. FS was diluted with high glucose DMEM (Gibco) containing 10% FBS (HyClone) and different concentrations of FS at 5%, 10%, 15%, 20% was used in following studies. Briefly, chondrocytes at passage 2, 4 were treated with 5%, 10%, 15%, and 20% FS of S. aureus, respectively, with medium changed every 2 days. Expression of AMPs was determined by qPCR and Western blot analysis at 3 and 7 days, respectively.
Cell Proliferation Assay
Cell proliferation was measured by CCK8 assay kit (Dongren, China) according to manufactory's instruction. Briefly, chondrocytes at passage2 were seeded in 96-well plates at a density of 2,000 cells/well and maintained in culture medium for 24 h. The culture medium was then removed and replaced by 100 ul of 10% FS. At days 1, 3, 5, and 7 after seeding, the optical density was determined at 450 nm using an enzymelinked immunosorbent assay reader (Thermo Fisher Scientific, Waltham, MA). Each experiment was conducted for at least three times and the average of the results was analyzed.
Quantitative Real-Time PCR Total RNA was extracted from the samples using TRIzol (Invitrogen, Carlsbad, CA) reagent according to the manufacturer's instructions. The concentration of extracted RNA was measured using a NanoDrop ND-1000 Spectrophotometer (Agilent, Palo Alto, CA). Using the PrimeScript RT reagent kit (Takara, China), 500 ng of total RNA were reversetranscribed. qPCR was performed using the SYBR PrimeScript RT-PCR kit (Takara, China) and the reaction mixtures were incubated at 95˚C for 1 min, followed by 40 cycles of 95˚C for 15 s and 60˚C for 1 min, using the ABI 7,500 System (Applied Biosystems, Foster City, CA). GAPDH was used as a housekeeping gene. The sequences of the primers used are listed in Table 1 . The differential expression level was calculated using 2 ÀDDCT formula. All the experiments were conducted at least three times.
Western Blot Analysis
Protein was extracted from the cells using RIPA lysis buffer (supplemented with protease inhibitors, phosphatase inhibitors) on ice for 15 min. The supernatants were collected following centrifugation at 12,000g at 4˚C for 10 min. For secreted protein detection, cell culture medium was concentrated with ultra-centrifuge tubes (Millipore) at 7,000 rpm for 30 min. The protein concentration was determined using a BCA protein assay kit (Tiangen, China), and whole lysates were mixed with 5x SDS loading buffer (125 mmol/l TrisHCl, 5% SDS, 20% glycerol, 100 mmol/l dithiothreitol [DTT], and 0.2% bromophenol blue) at a ratio of 1:4. The samples were heated at 100˚C for 10 min and were separated on SDSpolyacrylamide gels. The proteins were size-fractionated by SDS-PAGE then were transferred onto PVDF membranes. which were incubated in 5% skim milk powder in PBS containing 0.1% Tween 20 (PBST) for 1 h at room temperature. Following blocking, the membranes were incubated overnight at 4˚C with primary antibodies against Sox9 , CAMP (abcam, ab69484, 1:1000). After washing with PBST, the membranes were incubated in alkaline phosphatase conjugated secondary antibodies for 1 h. The blots were developed using a peroxidase-conjugated secondary antibody and ECL system.
Statistical Analysis
Quantitative data are presented as the means AE standard deviation (SD). The data were analyzed by two-tailed Student's t-test for means analysis to compare two data groups or ANOVA to compare three or more data groups. Only pvalues < 0.05 was considered to indicate statistically significant differences.
RESULTS

FS of S. Aureus Caused Dedifferentiation of Chondrocytes in a Concentration Dependent Way
To determine effect of S. aureus on articular cartilage, we exposed mouse articular chondrocytes at passage2 to FS at concentration of 5%, 10%, 15%, 20% for 7 days, respectively. As shown in Figure 1 , chondrocytes treated for 7 days with FS showed a characteristic fibroblast-like morphology, which is distinct from 444 LI ET AL. untreated (control) cells (Fig. 1A) . When exposed to 5%, 10%, 15%, and 20% FS, respectively, expression of COL II was decreased 2.3, 11.6, 12.1, and 13.5 times, Sox9 was decreased 2.1, 6.6, 6.8, 6.9 times, aggrencan (ACAN) was decreased 3.4, 12.5, 13.1, 14.2 times as revealed by qPCR, While, expression of fibro-cartilage characterized genes such as COL I was increased 7.9, 10.6, 11.2, 11.7 times, COL III was increased 8.3 and 12.1, 12.5, 13.1 times, respectively, (p < 0.05) (Fig. 1B) . Accordingly, changes of these genes was confirmed in protein level by Western blot analysis (Fig. 1C) . These results suggested that FS of S. aureus caused dedifferentiation of mouse chondrocytes in a concentration dependent manner. However, we found that cell viability was significantly decreased, when concentration of FS was more than 10% (data did not show). Therefore, we chose 10% FS as experimental concentration in the following studies.
Expression of Catabolic Factors was Increased in Dedifferentiated Chondrocytes Exposed to FS of S. Aureus
After treated with 10% FS of S. aureus for 7 days, cells acquired a more spindle fibroblast-like shape ( Fig. 2A) . As measured by CCK8 assay, addition of FS of S. aureus significantly stimulated proliferation of chondrocytes (Fig. 2B) . QPCR analysis revealed that expression of Sox9, ACAN, and COL II was significantly reduced (p < 0.05), respectively, after treatment with 10% FS for 7 days, at which time levels of these genes were remarkably lower than their expression at 3 days. Furthermore, exposure to 10% FS significantly increased dedifferentiation markers expression including COL I, COL III at 3 and 7 days (p < 0.05). Again, increased level at 7 days was much higher than that at 3 days (Fig. 2C ). In accordance with real time PCR analysis, Western blot evaluation showed downregulation of Sox-9, COLII, and up-regulation of COL I and COL III in protein level (Fig. 2D) . It is reported that expression of catabolic factors was initiated with dedifferentiation of chondrocytes in osteoarthritic cartilage. We thus investigated whether exposure to FS of S. aureus leads to a catabolic response in dedifferentiated chondrocytes. Treatment with 10% FS of S. aureus resulted in significant increased expression of catabolic factors including ADAMTS5, NOS2, MMP3, and MMP13 in chondrocytes at 3 and 7 days (p < 0.05), respectively (Fig. 2E) . More importantly, Western blot assay confirmed increased expression of these factors in protein levels (Fig. 2F) . These results suggested that, in accompany with dedifferentiation of chondrocytes as a result of exposure to FS of S. aureus, catabolic factors were activated which may induce subsequently ECM degradation of articular cartilage.
FS of S. Aureus Stimulated Dedifferentiated Chondrocytes to Produce Antimicrobial Peptides
We observed that chondrocytes expanded to passage4 exhibited a dedifferentiation phenotype featured with decreased expression of Sox9, ACAN, COL II, and enhancement in COL I and COL III expression (p < 0.05) (Fig. 3A and B) . We next examined the expression of AMPs including DEFA-1, -2, -3, -5, MBD-1, -2, -3, -4, and CAMP in chondrocytes stimulated with 10% FS of S.aureus. QPCR showed that expression of AMPs increased in response to 10% FS of S. aureus at 3 and 7 days (Fig. 3C-K) . It is noticeable that expression of these AMPs increased only slightly in P2 chondrocytes in the presence of 10% FS. While, significant increase of AMPs was detected in P4 dedifferentiated chondrocytes, which was more evident after 7 days (p < 0.05). Expression of CAMP in P2 chondrocytes increased 43 and 109 times after treatment for 3 and 7days, respectively. However, exposure to SF for 3 and 7 days resulted in 73 and 170 times increase of CAMP expression in dedifferentiated chondrocytes at passage 4 (p < 0.05). Because the greatest increase was observed in CAMP expression among AMPs detected, we performed Western-blot analysis to examine protein production of CAMP in P4 chondrocytes. The result showed that the most evident increase of CAMP occurred in dedifferentiated P4 chondrocytes after 7 days exposured to FS (Fig. 3K) . These results suggested that, with occurrence of dedifferentiation, chondrocytes produced more AMPs, especially CAMP, in response to FS of S. aureus stimulation.
Exposure to FS of S. Aureus Induced Expression of IL-1b, IL-17F, and IL-22 in Chondrocytes
As IL-1b has been reported to play a central role in shifting the anabolic and catabolic balance with dedifferentiation of chondrocytes, 9, 10 we detected expression of IL-1b in cells treated with FS of S. aureus for 3 and 7 days. Stimulation with FS of S. aureus resulted in a robust up-regulation of IL-1b (p < 0.05), respectively (Fig. 4) . Several evidences documented that production of AMPs was mediated by IL-17F and IL-22 in keratinocytes stimulated by S. aureus. 16 We thus analyzed the expression of IL-17 and IL-22 in chondrocytes at P2, P4, respectively, that treated with 10% FS of S. aureus for 3 days. By qPCR, we found transcriptional level of either IL-22 or IL-17F increased significantly in P4 chondrocytes as compared with their expression in cells of P2 (p < 0.05) (Fig. 5) . This result indicates that high levels expression of IL-22 and IL-17F in dedifferentiated chondrocytes may be responsible for an increased production of AMPs. 
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DISCUSSION
Despite treatments of septic arthritis including drainage, antibiotic therapy, and hospital care have been improved greatly, irreversible destruction of joint is reported to maintained as high as in 50% of bacteria infected joints. 17 As revealed by clinical epidemiology, the majority of septic arthritis patients were infected by Gram-positive bacteria and the most common bacterium isolated was S. aureus. (A and B) , Chondrocytes at P2 and P4 were culture for 3 day. Expression of sox9, ACAN, COL II, COL I, COL III were determined in chondrocytes at P2, P4, by qPCR (A) and Western blot (B), respectively. (C-J), Chondrocytes at P2 and P4 were subjected to 10% SF of S. aureus exposure for 3, 7 days respectively, expression of AMPs including DEAF-1, -2, -3, -5, MBD-1, -2, -3, -4, and CAMP were determined by qPCR. (K) The protein level of CAMP was determined by Western blot, GAPDH was used as loading controls. Values are the mean AE standard deviation. Ã p < 0.05 vs. controls. for 20% of septic arthritis reported by Eberst-Ledoux et al. 19 Here, our results showed that expression of Sox9, ACAN, and COL II was significantly reduced in articulated chondrocytes that treated with FS of S. aureus. Furthermore, 10% FS significantly increased expression of dedifferentiation markers including COL I, COL III. Sox9 is SRY-box (Sox) containing gene and acts as a major transcriptional factor controlling chondrogenesis. 20 COL II is major structural collagen fibril in cartilage that provides compressive and tensile strength by forming a fibrillar network with COLIX and COLXI. 21 While, by filling the interstices of collagen fibrillar network, aggrencan interacts with collagen fibrillar network to endue articular cartilage with compressive stiffness. 22 Therefore, once expression of Sox9, ACAN, COL II was reduced, and replaced with deposition of COL I and COL III, the function of articular cartilage in resisting deformation and compression was greatly diminished, leading to a loss of joint function and subsequent progression of osteoarthritis (OA). 23 In addition to deposition of COLI, COLIII, dedifferentiated chondrocytes have been observed to produce proteolytic enzymes such as ADAMTS5, NOS2, and MMPs to accelerate destruction of cartilage matrix in the progression of OA. Among these enzymes, MMP-13 predominantly cleaves COL II.
24 ADAMTS5 is responsible for proteoglycans degradation, 25 and NOS2 induced NO production which attribute to apoptosis of chondrocytes. 26 Our results showed that FS of S. aureus induced expression of ADAMTS5, NOS2, MMP3, MMP13 in mature differentiated chondrocytes at passage2. In previous study, Arican et al. observed an increased release of MMP-2 and -9 in the synovial fluids of patients with septic arthritis. 27 Sakurai et al. 24 reported Streptococcus pyogenes degrades extracellular matrix via stimulating MMP-13 in chondrocytes. Proteinase and hyaluronidase produced by bacterium have been associated with degradation of host ECM in infectious disease. 28 Taken together, these results indicate that, in addition to degradation by infected bacteria directly, release of proteolytic enzymes form host chondrocytes that exposed to bacteria plays an essential role in ECM destruction in S. aureus-induced septic arthritis.
Several lines of evidence showed that proinflammatory IL-1b acts as a major mediator in inducing dedifferentiation of chondrocytes. 9, 10 As expected, stimulation with FS of S aureus resulted in significant increase of IL-1b expression in chondrocytes. Given that matrix-degrading proteinases could be remarkably enhanced with up-regulation of IL-1b in osteoarthritic cartilage, we speculate that increased expression of IL-1b may be responsible for dedifferentiation of chondrocytes and the enhanced production of matrix degrading molecules.
AMPs is a diverse group of polypeptides that are typically less than 50 amino acids in length and exhibits bactericidal activity under physiologic conditions. 29 Expression of HBD2 was found strongly increased in cartilage after exposure to gram-negative bacteria and pro-inflammatory cytokines. AMPs against gram-positive bacteria including RNase-7, LL-37, and HBD-3 have also been identified in cultured human chondrocytes that challenged with S. aureus.
14,15 Therefore, we detected expression of MBD-1, -2, -3, and -4 CAMP in mature differentiated chondrocytes stimulated with FS of S. aureus. As chondrocytes undergoes dedifferentiation with the stimulation of S. aureus, it is of interests to investigate whether dedifferentiated chondrocytes are able to exert their protective effects against septic arthritis by producing AMPs. We found that, in response to FS stimulation, expression of AMPs including MBD-1, -2, -3, -4, and CAMP was significantly enhanced in dedifferentiated chondrocytes as compared to that in differentiated chondrocytes. In particular, CAMP is detected be increased to the highest level among the elevated AMPs in dedifferentiated chondrocytes challenged with S. aureus. CAMP constitutively expressed in neutrophils and can be induced in epithelial cells in response to S. aureus infections. 15, 30 These results DEDIFFERENTIATED CHONDROCYTES AND ANTIMICROBIAL PEPTIDES indicated that, with progressive dedifferentiation, chondrocytes acquired the ability to produce more AMPs against S. aureus. It has been reported that CAMP plays a critical role in maintaining the balance between pro-and anti-inflammatory responses by altering Toll-like receptor-to-NF-kB signaling pathway. 30 Thus, it is necessary to explore function of CAMP in modulating inflammation reactions in septic arthritis in future works.
Several studies demonstrated that production of CAMP and BD2 AMPs is mediated via IL-17F and IL-22. 16 Produced by Th17 cells, IL-17F has been shown to promote neutrophil recruitment for promoting host defense against S. aureus. 16 In agreement with AMPs expression, exposure to FS of S. aureus significantly increased expression of IL-17F and IL-22 in dedifferentiated chondrocytes as compared with chondrocytes at passage2.
In summary, our results showed that FS of S. aureus accelerated dedifferentiation of chondrocytes with suppression of Sox9, COLII, and increase of COLI, COLIII. With exposure to FS of S. aureus, dedifferentiated chondrocytes produced more matrix degrading enzymes including ADAMTS5, NOS2, MMP3, MMP13 than mature differentiated cells did. More importantly, we found that production of antimicrobial peptide CAMP was significantly enhanced by dedifferentiated chondrocytes in response to FS of S. aureus stimulation as compared with that in differentiated cells, indicating a potential self-protective mechanism in articular cartilage infected by S. aureu.
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